Creon DR 36,000 unit capsule UU 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FXTQ9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,916
Award facts
- Contract value 100% obligated
- $1,916.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,916.10 to AmerisourceBergen Drug Corp for the supply of Creon DR 36,000 unit capsules (100 count) on January 12, 2026, with completion scheduled for January 13, 2026. This non-competitive delivery order utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen is a major pharmaceutical distributor providing critical medical commodities across multiple therapeutic domains to federal agencies, particularly the Department of Defense and military healthcare systems. The company's federal contracting demonstrates extensive capability in supplying specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order for Creon, a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency, represents a routine fulfillment of the company's role as a primary pharmaceutical supplier within the DLA Troop Support Medical supply chain supporting military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FXTQ9?
SPE2DR26FXTQ9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FXTQ9 worth?
The government has obligated $1,916 on SPE2DR26FXTQ9.
Is contract SPE2DR26FXTQ9 an order under another contract?
Yes. SPE2DR26FXTQ9 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXTQ9 competed?
The extent of competition for SPE2DR26FXTQ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award